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The Specificity and Orientation of a TCR
to its Peptide±MHC Class II Ligands
Derek B. Sant'Angelo,* Greg Waterbury,* The genes encoding the T cell receptor (TCR) are
similar to immunoglobulin genes both in sequence andPaula Preston-Hurlburt,* Sangwook Tim Yoon,*²
in the way that they are assembled from gene segmentsRuslan Medzhitov,* Soon-cheol Hong,*
during development. Indeed, several studies suggestand Charles A. Janeway, Jr.*
that TCRs are structurally homologous to immunoglobu-*Section of Immunobiology
lins (Davis and Bjorkman, 1988; Chothia et al., 1988;Yale University School of Medicine
Claverie et al., 1989). Furthermore, recent crystallo-Howard Hughes Medical Institute
graphic studies of a TCR b chain clearly demonstrateNew Haven, Connecticut 06520-8033
the presence of CDR loops and an overall pattern of
immunoglobulin folding (Bentley et al., 1995). Despite
these similarities, important differences exist betweenSummary
the two receptor types. The genes encoding TCRs are
not subject to somatic hypermutation, unlike the genesA T cell±mediated immune response is mainly deter-
encoding antibodies. Therefore, the CDR loops are fixedmined by the 3±5 aa residues that protrude upwards
once recombination is complete. Importantly, this limitsfrom a peptide bound to an MHC molecule. Alterations
the sequence diversity of the V gene±encoded CDR1of these peptide residues can diminish, eliminate or
and CDR2 loops to that which is already present withinradically alter thesignal that the T cell receives through
the germline.its T cell receptor (TCR). We have used peptide immu-
The diversity of the T cell population is, therefore, lessnizations of normal mice and mice carrying a or b
than that of antibodies. This apparent deficiency may,chain TCR transgenes to identify three distinct peptide
however, be complemented by the ability of the TCR tocontact points. One, near the carboxyl terminus of the
form a very large number of variants in the CDR3 loopspeptide, involves the b chain CDR3 region; the second
by a variety of mechanisms (Davis and Bjorkman, 1988).was centrally located and interacted with both the a
This appears to be consistent with the nature of theand b chain CDR3 loops; the third was near the amino
ligand for the TCR. The TCR does not directly bind itsterminus of the peptide, and affected Va gene usage,
cognate antigen, but rather recognizes antigens as pep-but not the structure of CDR3 of either TCR chain.
tide fragments degraded within a cell and brought to itsBased on these results, we propose an orientation for
surface as a stable complex with a protein encodedthe TCR of this cloned line and argue for its generality.
within the major histocompatability complex (MHC)
(Germain, 1994). The determination of the structure of
Introduction human MHC class I and MHC class II molecules sug-
gests that only a small portion of the peptide is exposed
Adaptive immune responses occur by clonal selection for possible interaction with the TCR (Bjorkman et al.,
of lymphocytes bearing receptors whose antigen recog- 1987; Stern et al., 1994; Stern and Wiley, 1994). The
nition domains are encoded by genes that are assem- architecture of the TCR ligand suggests that only some
bled by the somatic rearrangement of linked gene seg- of the TCR CDR loops need to be in direct contact
ments during lymphocyte development (Tonegawa, with the peptide, while some of the other CDRs may be
1983; Davis and Bjorkman, 1988). The tremendous vari- involved incontacting the MHC protein. Since theoverall
ety of receptor sequences generated by this process structure of the MHC appears to be remarkably constant
results in a remarkably diverse population of lympho- (Stern and Wiley, 1994), it is likely that less diversity
cytes capable of responding to a vast number of anti- would be required for the nonpeptide-contacting CDRs.
genic epitopes (Percus et al., 1993). Indeed, several studies demonstrate that the CDR
B cells produce immunoglobulins that meet this anti- loops of theTCR do interact with both the MHC molecule
genic onslaught by generating even greater receptor as well as with the antigenic peptide (Hong et al., 1992;
diversity by somatic hypermutation, which also contrib- Jorgenson et al., 1992; Luescher et al., 1995). By analogy
utes to affinity maturation (Berek et al., 1991; Yelamos to antibodies, it is believed that the CDR3 loops occupy
et al., 1995). These somatic mutations occur primarily the center of the TCR binding site. Since the foreign
in the variable gene segments and appear to cluster antigenic peptide occupies the center of the MHC mole-
within the sixhypervariable loops known as complemen- cule, it seemed likely that the CDR3 loops will contact
tarity determining regions (CDRs) (Both et al., 1990; Betz the peptide (Danska et al., 1990), and this has now been
et al., 1993; Yelamos et al., 1995). This is crucial, since confirmed experimentally (Jorgenson et al., 1992).
antibody±antigen contact is dependent on precise inter- Here, we argue that the advantage gained by having
actions between the antigen and these CDR (Amit et the TCR recognize self-MHC molecules as part of the
al., 1986). The probability that an immunoglobulin can antigenic complex would only exist if all TCRs interact
interact with a given antigen is also greatly enhanced with the MHC in the same orientation. In this paper,
by its ability to bind antigens in a variety of orientations we demonstrate the orientation of a particular TCR by
(Davies et al., 1990). immunizations of normal mice and of mice carrying
transgenes encoding a single chain of a TCR specific
for a 9 aa peptide of the protein conalbumin (CA). Immu-²Present address: Department of Orthopedic Surgery, University of
California, San Francisco, California 94143. nizations were performed with the wild-type peptide
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Table 1. Alignment of MHC Class II Peptides and I-Ak-Derived Peptides
Peptide (MHC allele) Sequence Reference
P1 P4 P6 P9
CA (I-Ak H RG A I E WE G IESG
HEL (I-Ak) DGST D YG I L Q IN S RW (RoÈ tzschke and Falk, 1994)
cytC (I-Ek) ANERADL I AY L K Q AT K (Jorgensen et al., 1992)
Hb (I-Ek) GKKV I TA F N E GL K (Evavold et al., 1993, 1995)
CLIP (Mouse) SAKPVSQ M RM A T P LL M RPMS (Sette et al., 1995)
CLIP (Human) PPKPVSK M RM A T P LL M QALP (Malcherek et al., 1995; Ghosh et al., 1995)
huCollV (I-As) EA I QP G C I GG P K (Pfeiffer et al., 1994)
PLP (I-As) H S LG K W L GH P DKF (Kuchroo et al., 1994)
MSA (NOD) KPKAT A EQ L K T VN D D (Reich et al., 1994)
HA (DR1) PK Y VK O N T LK L AT (De Magistris et al., 1992; Stern et al., 1994)
TT (DR1) Q Y IK A N S KF I GI (De Magistris et al., 1992)
D10 (CA-wt) H RG A I E WE G IESG
KGT D FQ L N Q LE G KKG (Marrack et al., 1993)
EYVRF D SF V G E YR A VT
XPL A LQ F A E LP V NKG
EENLRF D SD V G E FR A V
SYL D AW V C E QL A T
DGST D YG I L Q IN S RW (Nelson et al., 1992)
II A ND Q G N RT T PSY
EPLVPL D NH I P E NA Q PG
Experimental data from listed references suggest that peptide residues in bold contact the TCR and that underlined residues interact with
the MHC class II molecule. P1, P4, P6, and P9 refer to the MHC class II peptide-binding pockets.
(CA-wt) and with peptides that vary from the CA-wt the nature of peptide±MHC class II interactions. Such
informationhas suggested at least four primary peptide±peptide by a single amino acid near the carboxyl termi-
nus (p8), at the central residue (p5), or near the amino MHC interaction sites and between 3 and 5 peptide
residues that areexposed for potential TCR interactions.terminus (p2). Our data clearly demonstrate that the
carboxyl terminus of the peptide affects TCR Vb CDR3 The cloned T cell line D10.G4.1 (D10) (Kaye et al.,
1983) recognizes a peptide derived from the chicken CAstructure, while the centrally located amino acid at p5
interacts with the CDR3 equivalents of both the a and protein (residues 134±146) bound to the MHC class II
molecule I-Ak (Nakagawa et al., 1991). To define howb chain of the TCR. Finally, we were able to associate
the residue at p2 with selective usage of different Va the CA peptide is bound to I-Ak and which residues are
likely exposed potentially to contact the TCR, we reliedgene segments. These data differ from previously pub-
lished analyses both in identifying contacts of p5 with on comparison of biochemical data for the CA peptide
(Nakagawa et al., 1991; Yoon, 1994) with data availableboth the a and b chain CDR3 (see Jorgensen et al.,
1992), and in identifying a contact in Va with the amino for severalother peptides. This analysis suggests a com-
mon architecture for many of these MHC class II±peptideterminus of the bound peptide. Most strikingly, there
was stringent selection for CDR3 amino acid sequence complexes (Table 1). Further comparison of the CA pep-
tide to peptides derived from I-Ak (Nelson et al., 1992;in mice with a rearranged TCR b chain transgene, sug-
gesting a direct effect of the antigenic peptide on the Marrack et al., 1993) suggested a peptide binding motif
TCR during antigen recognition in the periphery the anti- for this MHC class II allele, as shown in the lower part
genic peptide or during ontogeny in the thymus. These of Table 1. Of fifteen examined peptides, seven have a
data allow us to propose a model for the rotational orien- distinct pattern of amino acid residues that fall into the
tation of this TCR to its peptide±MHC class II ligand. We p1, p4, p6 and p9 configuration seen for other MHC
believe that this model accommodates other published class II alleles. This alignment strongly suggests that
data and, therefore, we argue that this model represents both pocket 1 (P1) and pocket 6 (P6) of I-Ak prefer nega-
the general orientation of the TCR to its peptide±MHC tively charged or hydrophilic residues (usually aspartic
class II ligand. acid at P1 and glutamic acid at P6). The peptide residue
usually found in P4 is hydrophobic, while the ninth posi-
Results tion of the peptide is typically found to be a small un-
charged residue.
Based on MHC class II homology modeling, we haveThe D10 MHC Class II±Peptide Ligand
MHC class II±derived peptide sequence analysis (Ram- determined that one of the polymorphic residues that
makes up P1 (residue 85 of the I-Ab chain) is a lysine inmensee et al., 1995), the HA peptide±DR1 crystal struc-
ture (Stern et al.,1994), and biochemical data (Jorgensen I-Ak, resulting in a positive charge in P1 and explaining
the preference for negatively charged and hydrophilicet al., 1992; Evavold et al., 1995) have helped define
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residues in the bound peptides at this position. Addi-
tional polymorphisms in the I-Aka chain result in threo-
nines at amino acid positions 11 and 65. These residues
affect P6 and could explain the hydrophilic amino acid
residue suggested in the binding motif. Finally, two of
three polymorphic residues in P9 are large hydrophobic
residues (isoleucine and leucine at positions 72 and 73,
respectively, of the I-Akb chain), suggesting a small
pocket likely to bind small uncharged peptide residues
like the glycine at p9 in CA 134±146.
Recognizing the similarities that exist between many
MHC class II±peptide complexes and determining a
likely predominant binding motif for I-Ak allowed us to
predict that p2, p3, p5, p7, and p8 of the CA peptide
are exposed for TCR interaction, while p1, p4, p6, and
p9 are the likely MHC binding residues. Indeed, the re-
sponse of D10 to an extensive array of single amino
acid peptide variants and peptide truncation variants
demonstrated that amino acid alterations at CA peptide
positions p2, p3, p5, p7, and p8 greatly reduce the re-
sponse of D10, while amino acid alterations at positions
p1, p4, p6, and p9 generally do not affect the response
of D10 (Yoon, 1994; Dittel et al., submitted). This pattern
of 3±5 aa residues that are exposed for contact with the
TCR and 4 residues that are likely involved with binding
MHC class II is consistent with structural studies of
various MHC class II molecules (Stern et al., 1994; D.
Figure 1. Response of Selected T Cell Hybridomas Derived fromFremont, personal communication).
Mice Carrying a Transgene for the D10 a Chain that Were PrimedThis MHC class II±peptide model allowed us to make
with the CA-wt Peptide or Its E8A Variantpredictions concerning the role of specific peptide resi-
The hybrids were formed by fusion to BWa2b2 fusion partner asdues in TCR interactions. The validity of these predic-
described in Experimental Procedures. They were screened for re-
tions was analyzed by a peptide immunization strategy. sponse to the immunizing peptide, cloned, and assayed as shown
here for response to CA-wt or E8A peptide. The hybrids are repre-
sentative of groups of hybrids with similar response patterns: (A)Position Eight of the CA Peptide Interacts
hybrid 3D3, primed with CA-wt; (B) hybrid 2A1, primed with CA-wt;with the CDR3 Loop of the TCR b Chain
(C) hybrid 1C6, primed with E8A; (D) hybrid 2B1, primed with E8A.Alteration of position eight (p8) of CA-wt from a glutamic
The response of the T cell hybridomas was determined by IL-2acid to an alanine dramatically reduces the response of
release as measured by thymidine incorporation into the IL-2-sensi-
D10 cells to this peptide (E8A). In terms of the above tive cell line, CTLL-2.
model, this suggested tous that p8 of CA was analogous
to p102 of the moth cytochrome C (MCC) peptide pre-
sented by I-Ek, which has been suggested to interact
that the b chain CDR1 and CDR2 loops in these T cellswith the CDR3 loop of the TCR b chain. In the earlier
are identical. Differences in peptide reactivity can there-case, however, different Vb genes were utilized in re-
fore be attributed only to sequence variations seensponses to the native MCC peptide (Vb3) than were
within the putative CDR3 loop of the b chain, as all theused in response to the p102 mutant (Vb8.1, Vb8.2, Vb6,
hybrids express the transgene-encoded TCR a chain asVb1, or Vb4), possibly clouding interpretation of the data
determined by cell surface staining and RT±PCR (data(Jorgensen et al., 1992; Katayama et al., 1995). There-
not shown). As shown in Figure 2, the Jb segmentsfore, we immunized mice carrying a D10 a chain
are highly conserved, while the CDR3 coding segmentstransgene with either CA-wt peptide or the altered pep-
show both length and sequence variation. Within a par-tide, E8A. T cellhybridomas generated from these immu-
ticular group (i.e., the E8A-specific hybridomas), how-nizations were tested for peptide specificity and the TCR
ever, the CDR3 sequence and length diversity is quiteb chain genes were analyzed by sequencing polymerase
limited.chain reaction (PCR)-amplified cDNA.
Positively charged residues were selected in responseAs shown in Figure 1, the T cell hybridomas could
to the glutamic acid at p8 of the CA-wt peptide in onlybe separated into three groups, CA-wt reactive, E8A
two hybrids (1D2 and 1B2). However, a negativelyreactive, or cross-reactive toboth E8A and CA-wt. Some
charged aspartic acid was selected in all five of the Tcross-reactive T cell hybridomas recognized the two
cell hybridomas that responded to E8A and not to CA-peptides equivalently, while most hybrids derived from
wt. These data agree with those of Jorgensen et al.mice immunized with CA-wt showed a strong or abso-
(1992), with the exception that in this case, variation waslute preference for response to CA-wt. Importantly, se-
limited to CDR3 and Jb, with all the hybrids expressingquence analysis determined that all the hybridomas uti-
lized the Vb8.2 gene segment (Figure 2), demonstrating Vb8.2.
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of the MCC peptide. The Jorgensen et al. (1992) data
suggests that p5 interacts with TCR a chain CDR3. To
explore the role of the fifth residue of the CA-wt peptide,
we made two different mutations, I5K and I5A. Normal
B10.BR mice, and mice bearing transgenes encoding
only the D10 TCR a chain or b chain were primed with
these peptides. As shown in Figure 3A, B10.BR mice
immunized with the peptide I5K responded to it, but
did not respond to CA-wt peptide; the same result was
obtained in I5A-primed mice (data not shown). However,
mice carrying a transgene encoding the D10 TCR b chain
and primed with I5K did not respond to peptide at all,
although a very high background was seen in the ab-
sence of peptide (Figure 3B). Likewise, when mice car-
rying the D10 TCR a chain were immunized with I5K,
they responded very poorly and nonspecifically to both
peptides (Figure 3C, note difference in scale). Again,
very similar data were obtained with I5A (data not
shown).
When T cells from B10.BR mice primed with I5K were
cultured with I5K, they were strongly activated (Figure
3A), and the activated T cell blasts were shown to ex-
press predominantly Va2 and Vb8; these Va21, Vb81 T
cells make up about one-third of the total responding
population (Figure 3D). As Va2 represents about 5%±
Figure 2. Sequences of b Chains from T Cell Hybridomas Derived 10% of all T cells, and Vb8.2 about 10% of all T cells in
from Mice Transgenic for the D10 TCR a Chain Primed with CA-wt B10.BR mice, this represents a 30- to 60-fold increase
or E8A and Tested for Specificity as Shown in Figure 1
in frequency after a short culture with the mutant pep-
PCR-amplified cDNA was directly sequenced at least two times. All
tide. This substantial increase in the frequency of TCRresponding hybridomas expressedVb8.2. Hybridomas with identical
a and b chain usage resembles the results reportedsequences are shown in parentheses below the number for the
recently by McHeyzer-Williams and Davis (1995) in theindex sequence. Expression of both the endogenous Vb and the
response of B10.A mice to immunization with an anti-transgenic D10 Va2 was confirmed by cell surface three-color stain-
ing with antibodies for Va2, Vb8, and CD4. genic peptide from pigeon cytochrome c, in which a 27-
fold increase of T cells using a specific Va and Vb is
seen.Alterations in the Peptide Residue p5 Alters Both
When we formed T cell hybrids with these cells, allthe a and b Chain CDR3, While Conserving
the Va and the Vb Gene Segments Used the hybrids responding specifically to I5K expressed
Our model for CA-wt±I-Ak binding suggests that p5 of Va2 and Vb8.2 (Figure 4A), while only one of these hy-
brids also reacted with the CA-wt peptide (Figure 4B).the peptide is exposed and is likely analogous to p99
Figure 3. The Response of T Cells from the
Draining Lymph Nodes of Nontransgenic
Mice and of Mice Carrying Transgenes En-
coding the D10 b or the D10 a Chain after
Immunization with Peptide I5K
Proliferation assay of 1 3 105 cells/well from
draining lymph nodes of (A) a B10.BR mouse;
(B) a mouse carrying the transgene encoding
the D10 b chain; and (C) a mouse carrying
the transgene for the D10 a chain. The re-
sponse in (B) was not dependent on peptide,
as close to 30,000 cpm were recorded when
no peptide was added. Note the change of
scale in (C). (D) FACS analysis of lymph node
CD41 T cells from a B10.BR mouse primed
with I5K after 11 days in bulk culture with the
I5K peptide.
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Figure 4. T Cell Hybridomas Derived from
Nontransgenic Mice primed with I5K Re-
spond to I5K
Most hybridomas derived from B10.BR mice
primed with I5K respond only to I5K (A), but
one (43.4) responds to CA-wt peptide as well
(B). T cell hybridoma assays were performed
as described in Figure 1.
Sequence analysis of the a and b chains of these hybrids difference from CA-wt in their ability to compete with a
biotinylated reference peptide for binding to solubilizedconfirmed the expression of Va2 and Vb8.2. The TCR
I-Ak. Therefore, while p2 altered peptides affect the re-in these hybrids differed from D10 only in the CDR3
sponse of D10 cells by up to 150-fold, their ability toloops of the a and b chains and in Ja and Jb gene
bind I-Ak is not affected (Yoon, 1994).segment usage (Figure 5). By careful inspection of the
To determine where p2 interacts with the TCR, micesequences, it can be seen that two hybrids, 15.1 and
transgenic for the D10 b chain or the D10 a chain were43.4, have identical a chain sequences and differ only in
immunized with the CA-wt and the R2D mutant peptide.the b chain CDR3 and in Jb. These two hybrids respond
We reasoned that the change in R2D, which involvesdifferentially to I5K and CA-wt: both hybrids respond to
both a charge reversal as well as a significant aminoI5K, while only 43.4 responds to CA-wt. These T cells
acid side chain alteration, should have a marked effectdiffer by the presence of a glutamic acid residue in the
on TCR usage if it is a TCR contact residue. As shownb chain CDR3 of hybrid 15.1, and we believe that this
in Figure 6A, T cells derived from D10 TCR b chainmakes a significant difference in their responses to this
transgenic mice respond specifically to the R2D peptidepeptide. However, this needs to be confirmed by site-
and not to the CA-wt peptide, while T cells derived fromspecific mutagenesis. Taken together, these data
a mouse transgenic for both the a and b chain genesstrongly suggest that the residue at peptide position p5
of the D10 TCR that were propagated in vitro by expo-interacts with both the a and b chain CDR3 loops. This
sure to CA-wt peptide in the absence of immunizationresult differs from earlier studies of this position; Jorgen-
respond about 50-fold less well to the R2D mutant thansen et al. (1992) only detected the a chain contact, but
to CA-wt (Figure 6B). Immunization of mice carrying aas they immunized mice with a b chain transgene, that
transgene for the a chain of the D10 TCR with the R2Dwas all that these authors could expect to observe. This
peptide respond nearly identically to the D10 TCR linemay reflect a fundamental difference in TCR recognition,
(Figures 6B and 6C). For this reason, hybridomas wereor it may just be a result of how the different experiments
not prepared from such cells, as we had no way towere performed.
discriminate their TCR from that of D10 itself. T cell
hybridomas generated from bulk cultures derived fromAlterations of Peptide Residue p2 Affects
TCR b chain transgenic mice immunized with R2D main-Va Gene Usage
tain the specificity for R2D, and specifically do not re-Finally, our peptide interaction model also suggests that
spond to CA-wt (Figures 6A and 6D). PCR and cell sur-residues near the amino-terminal end of the peptide
face staining determined that all 13 of the T cellshould be exposed to solvent and could potentially inter-
hybridomas derived from b chain transgenic miceact with the TCR. Single amino acid alterations at posi-
primed with R2D used the Va8 gene segment, while D10tion two of the CA peptide do indeed affect the response
and all 22 hybrids raised against CA-wt use Va2.of D10 (Yoon, 1994). Importantly, peptide binding assays
Sequence analysis determined that both the CDR1done for three CA peptides that vary at p2 show little
and CDR2 regions of the hybrids specific for R2D were
different from those in the D10 a chain sequence and
the sequence used in hybrids raised against CA-wt in
these segments (Figure 7A). It is noteworthy that the
R2D peptide-specific T cells show a net gain of two
positively charged residues in theCDR2 loop, potentially
in response to a net gain of two negative charges by
the R2D peptide mutation. Alternatively, there is a net
loss of three negative charges in CDR1 in this Va gene
segment as well. These significant differences are likely
Figure 5. I5K-Specific T Cell Hybridomas Use the Identical Va and due to a direct interaction with the aspartic acid at p2
Vb Gene Segments as D10, but Have Different CDR3 Regions of the R2D peptide with either CDR1 or CDR2, and could
Sequences of the TCR a and b chains from I5K-responsive T cell explain the preference for Va8 gene segment usage in
hybridomas derived from I5K-primed normal B10.BR mice (see Fig-
responses to R2D.ure 4). cDNA was PCR amplified with Va2 and Ca primers or Vb8
The CDR3 loop, which is derived from VJ recombina-and Cb primers and directly sequenced. Cell surface expression of
tion, was different from D10 in the region encoded bythe TCR was confirmed by three-color cell surface staining with
antibodies for Va2, Vb8, and CD4. N nucleotides (threonine in D10 and in all hybrids raised
Immunity
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Figure 7. The Amino Acid and Nucleotide Sequences of the Peptide
Contacts of the D10 TCR with Its Peptide Ligand
A comparison of the CDR loops of the TCR a chain from D10, 22
hybrids derived from mice carrying a transgene for the D10 TCR b
chain primed with CA-wt and responding to CA-wt, and 13 R2D-
specific T cell hybridomas from b chain transgenic mice primed
with R2D. Sequences of the R2D-specific T cells were determined
by PCR amplification using Va8- and Ca-specific primers, while
those from CA-wt-primed mice were identified with Va2- and Ca-
specific primers. The D10 sequence is from Hong et al. (1992). PCR
products were directly sequenced at least twice. Cell surface ex-Figure 6. The Position 2 Mutant Peptide (R2D) Affects T Cell Re-
pression of the TCR a and b chains was confirmed by three-colorsponse
cell surface staining with antibodies for Va2 or Va8, Vb8, and CD4.T cells of mice carrying a transgene encoding the D10 b chain (A),
(A) Amino acid sequences for D10, AV2S5 (Va2) from CA-wt andthe D10 TCR (a and b chains cointegrated) (B), or the D10 a chain
AV8S6 (Va8) from R2D-immunized D10 TCR b chain transgenic mice(C) were primed with R2D and restimulated with R2D or CA-wt as
were deduced from cDNA sequencing. The complete sequence andshown (A and C), or were stimulated as a T cell line carried on
approximate location of CDR1, CDR2, and CDR3 is shown, whileCA-wt (B). Representative T cell hybridomas (D) derived from mice
only a small portion of the framework regions (FR2 and FR3) iscarrying a transgene for the D10 b chain that were primed with R2D
shown. All 22 of the CA-wt-specific hybrids were identical in aminorespond only to R2D. None of the hybrids respond to CA-wt (only
acid sequence to the parental D10, while all 13 of the R2D-specificone example is shown).
TCRs used a different amino acid sequence, but all were identical(A and C) Cells/well (1 3 105) from the draining lymph nodes of mice
to each other.primed with R2D stimulated with the R2D peptide. Proliferation was
(B) Va8 CDR3 nucleotide sequences reveal extensive silent varia-determined by direct thymidine incorporation.
tions.(B) T cell line cells (5 3 104) were stimulated by CA-wt or R2D, pulsed
(C) The Va2 CDR sequences show differences only in the third basewith thymidine after 48 hr, and harvested after 72 hr; proliferation
of the N nucleotide±encoded residue threonine.measured was in the same way.
Number sign indicates number of independent clones with this se-(D) Hybridomas were prepared and assayed as described in Fig-
quence/total number of Va sequences. Letters in bold are differ-ure 1. Of 13 hybridomas, 4 with this response pattern are shown.
ences between the CDR1 and CDR2 sequences that may explain
the difference in peptide specificity in these different Va chains.
against CA-wt, and glutamic acid, glycine, and proline
in all the R2D-specific hybrids). All of these hybrids used
DiscussionJa15, which is also found in a chains from D10 (Figure
7A).
The experiments reported in this manuscript provideAlthough the Va CDR3 residues encoded in N nucleo-
strong evidence for the orientation of the TCR of thetides differ from those in D10, the CDR3 regions of all
cloned CD4 T cell line D10.G4.1 (D10) to its peptide±13 of the a chains of the R2D specific hybrids were
MHC class II ligand. This is based in part on the orienta-identical to each other in amino acid sequence (Figure
tion of the peptide as we depict it (see Table 1). This7A). Strikingly, despite identity in the amino acid se-
orientation of peptides bound to MHC class II has al-quence throughout CDR3 in each hybridoma, we found
ready been demonstrated for a number of peptides; bynine different nucleotide sequences (Figure 7B). All the
contrast, there is no evidence for an alternative orienta-nucleotide differences, however, resulted in silent
tion of peptides binding to either MHC class I or MHCchanges. A similar result is seen when mice transgenic
class II. A number of peptides were eluted from I-Ak byfor the D10 b chain were immunized with CA-wt peptide.
Nelson et al. (1992) and Marrack et al. (1993), and mostIn this case, all the analyzed T cell hybridomas (22/
showed an acidic residue in the latter half of the peptide,22) had Va2 chains with CDR3 amino acid sequences
predominantly glutamate, which we believe is the resi-identical to D10, but some of these (12/22) differed by
due at p6, also a glutamate in the CA peptide 134±146silent base changes in the codon for threonine, which
(see Table 1).is the only residue that falls in the region of N nucleotide
This being the case, we proceeded to examine severaladditions, proving the independent origin of at least
three sequences (Figure 7C). variant peptides for their ability to interact with the D10
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TCR in D10 TCR transgenic cells, and in hybrids raised contrast, mutations at p2 and especially p8 antagonize
activation completely or nearly completely (Dittel et al.,by immunization of normal mice as well as mice carrying
transgenes encoding either the rearranged gene for the submitted; Yoon et al., 1994).
Finally, we asked what would be the effect of primingD10 TCR a or the D10 TCR b chain. First, when we
immunized mice carrying a transgenic D10 TCR a chain mice that carry the D10 TCR b chain as a transgene
with the CA-wt peptide or the mutant peptide R2D. Wewith CA-wt or with a peptide mutated at p8, E8A, we
obtained cells that would respond to differing degrees to found that CA-wt peptide elicited a response that con-
sisted of T cells with an a chain amino acid sequencethe CA-wt peptide and to the E8A mutant. The response
appeared to correlate with the length and charge of the identical to that of D10; however, silent third base pair
changes in the part of CDR3 contributed by N nucleotideb chain CDR3, since all the receptors had the transgene-
encoded a chain and used Vb8.2, the same Vb gene insertion identified at least three of these as indepen-
dently derived a chains, as all three possible bases wereused by D10 cells. From this, we infer that CDR3 of the
b chain makes contact with the residue at p8 and is found at roughly the same frequency. When we immu-
nized the same mice with a peptide where the mutationinfluenced by it. This result is in agreement with results
reported by Jorgensen et al. (1992), but differs from R2D was introduced, we raised T cells that all used a
Va gene segment (Va8) different from that seen in theresults reported by Kelly et al. (1993). In neither of these
earlier studies, however, were all the resultant T cells CA-wt peptide immunizations (Va2). This strongly sug-
gests that the amino acid residue at p2 interacts withusing the same Vb gene segment; indeed, in Jorgensen
et al. (1992), entirely different Vb gene segments were the germline-encoded Va gene segment. The finding of
a net gain of two positively charged residues in CDR2used in response to wild-type or mutant peptides. Thus,
this is clear evidence for direct interaction of p8 of the of Va8 or of the loss of three negatively charged residues
in CDR1 of Va8 in response to the negatively chargedantigenic peptide with a CDR3 loop of the b chain.
Next, we primed mice with peptides that differ at p5, residue at p2 of the R2D peptide suggests that one of
these loops contributes to the contact site, but this mustand we found that neither mice carrying a transgene-
encoded D10 TCR a chain nor mice carrying a transgene be confirmed by site-specific mutagenesis, or by re-
placement of the CDR1 or CDR2 loop of the D10 a chainspecifying the D10 TCR b chain would respond signifi-
cantly to these peptides, I5A and I5K (Figure 3; data not by that from Va8.
This setof Va8-encoded a chains was also remarkableshown). By contrast, T cells from normal B10.BR (I-Ak)
mice responded specifically to the immunizing peptide, in that, as in the CA-wt immunizations, all 13 of the a
chains had an identical amino acid sequence in CDR3but these cells and 3 of 4 T cell hybridomas derived
from them do not respond to the CA-wt peptide. This (Figure 7), a site that is normally highly variable in TCRs.
In this case, there were 9 unique sequences at the nucle-response is made by cells bearing Va2 and Vb8.2, which
are the same gene segments found in the D10 TCR. otide level, demonstrating the independent origin of at
least 9 of these 13 a chains. As with the CA-wt immuniza-From this, we inferred that the CDR3 of both the a and
the b chain must interact with peptide p5. This was tions, this demonstrates intense selection for CDR3a at
the level of amino acid sequence.confirmed by sequencing the Va and Vb chains, which
are identical in the V gene segments used by the D10 The finding of identical amino acid sequences in the
CDR3 of all these T cell hybrids, whether they are spe-TCR but differ from D10 in the CDR3 regions of both
chains. The finding that the net charge of CDR3a and cific for CA-wt or R2D, raises interesting questions. First,
it may point to structural constraints of a chain V regionsCDR3b is 11 in D10 and the one hybrid that can respond
to both CA-wt and I5K, but ranges from 0 to 22 in the required for a chain stability or for ab pairing, since
the Vb is fixed in b chain transgenic mice. This seemsI5K-specific hybrids appears to confirm this result. This
finding differs from thereported results of either Jorgen- unlikely, as a chains can have highly diverse structures,
and can pair with most b chains. Also, analysis of Tsen et al. (1992) or Kelly et al. (1993). However, close
examination of the Jorgensen et al. (1992) data reveals cells bearing two a chains and one b chain show no
similarities in the sequence of the CDR3s of the two athat mice transgenic for the b chain respond 3- to 5-
fold less well than normal mice to mutations at p99. chains (Padovan et al., 1993). Alternatively, it is possible
that the identity in amino acid sequence seen in theseTaken together, these results suggest that the CDR3
loops of both a and b chains touch a variety of peptide Va domains is based on selection by antigen in the
periphery. However, we favor a different explanation ofside chains (p5, p8) pointing up or out of the cleft, and
that little can be learned about the rotational orientation this result. During T cell development, TCR b chains are
rearranged first, and recent data suggests that the soleof the TCR from studies that involve only CDR3 loops.
Evavold et al. (1995) have studied the role of the p5 criterion for the further development of T cells is for the
b chain to be in the correct reading frame (Dudley etposition in peptides they have analyzed, and have ar-
gued that p5 is the immunodominant residue in all pep- al., 1994). There follows a burst of proliferation, after
which a chains rearrange at random. The expressed abtides; Freemont (personal communication) argues that
the side chain of this residue is the ªlynchpinº of the TCR is then tested for its ability to recognize self-MHC
molecules, presumably loaded with self-peptides. Wepeptide ligand. Our results give direct experimental evi-
dence that these interpretations are valid. Moreover, like believe that the data we have obtained could support
such an hypothesis, but it will need a different approachEvavold et al. (1995), we have substituted all 20 residues
at this position, and these changes collectively either to confirm it.
A number of considerations further suggest that thedestroy antigen recognition entirely, or fail to generate
peptides that can antagonize recognition of CA-wt. By orientation of the D10 TCR to its peptide±MHC class II
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ligand will be a general model for the orientation of the positive selection independent of peptide dose (Jame-
TCR of CD4 T cells to their MHC class II±peptide ligands. son and Bevan, 1995; Jameson et al., 1994; Hogquist
First, the uneven surfaces of both MHC class I and MHC et al., 1994). As these peptides can be demonstrated to
class II molecules are largely established by differences interact with the TCR in the same orientation as the
in the peptide backbone of the two classes of molecule, native antigenic peptide, it is probably essential that the
rather than by amino acid side chains or folding differ- receptor not vary the way in which it interacts with the
ences when different peptides are bound. MHC class I MHC class II molecule during its development and, later,
has a prominent raised portion on the N-terminal end in the periphery. We believe that peptide is playing a
of the a helical region of the a1 domain, while MHC role in the selection of a chain CDR3 sequences in mice
class II has no helix in this region. Sun et al. (1995) carrying a rearranged b chain transgene, but this has
recently provided data that suggest that this area is yet tobe proven. Finally, the fact that all peptides appear
avoided by the TCR on CD8 T cell clones. However, our to lie in the same orientation in the peptide-binding
earlier studies strongly suggest that this is an area of groove argues for a defined orientation of the TCR to
contact for CD4 T cells (Hong et al., 1992; S.-c. H., its peptide±MHC class II ligand.
unpublished data). MHC class II shows a more promi- In summary, we have used, in part, an elegant genetic
nent bulge in the N-terminal half of the a helical region approach pioneered by Jorgensen et al. (1992), and this
of its b chain, bending up at residues 65±70. The analy- has allowed us to demonstrate a specific orientation for
ses of Sun et al. (1995) show this is an area also avoided the D10 TCR to its peptide±MHC class II ligands. The
by MHC class I±specific CD8 T cells, while we find inter- orientation we propose fully accommodates published
action between these residues and a residue in CDR1 of data, yet is substantially different from that proposed by
the TCR b chain (Hong et al., 1992; S.-c. H., unpublished Jorgensen et al. (1992).The reason for thediscrepancy is
data). These contrasting results could imply slightly dif- that most existing work has only considered the cen-
ferent orientations of the receptors on CD4 and CD8 T trally located CDR3 loops of the TCR. By aligning the
cells to MHC class I and MHC class II, an idea also CDR1 or CDR2 loops of the a chain with the amino
supported by the data of Kelly et al. (1993) on the role terminus of the peptide and CDR3 of the b chain with
of CDR3 residues in peptide recognition. However, this the carboxyl end of the peptide (see Figure 8), we are
may not always be the case, since there are well-docu- now able to confirm previous work concerning the D10
mented cases of cloned T cell lines that recognize pep-
TCR (Hong et al., 1992). In addition, we have shown that
tide with MHC class II and are alloreactive to MHC class
the critical nature of p5 of the antigenic peptide in TCR
I (Schilham et al., 1986).
recognition is probably the result of its interaction with
A second reason for favoring a single orientation for
the CDR3 loops of both chains of the TCR. Finally, we
the TCR on CD4 T cells is the finding that immunization
have also shown unequivocal evidence for the interac-
of normal mice with defined peptides yields a high per-
tion of b chain CDR3 with p8. Most intriguingly, we havecentage of responding T cells with identical Va and Vb
found a strict conservation of a chain CDR3 amino acidusage to the originating clone. This is seen in our own
sequences in mice with a transgene for the b chain ofdata by immunization with CA-wt or I5K peptides, and
the TCR (see Figure 7), and we propose that this reflectsalso in several earlier studies and one recent study of
the role of peptides either during the response to antigenthe response to pigeon cytochrome c presented by I-E
in the periphery, or during positive selection within themolecules (Fink et al., 1986; Winoto et al., 1986;
thymus.McHeyzer-Williams and Davis, 1995). Virtually all T cells
making this response use Va11 and Vb3. Because I-Ea
Experimental Proceduresis invariant, most of the changes in cloned T cell lines
reflect variation in the polymorphic I-Eb chain. I-Eb se- Mice
lects different Vb gene segments depending on the Eb The B10.BR mice used in these studies were obtained from the
genotype expressed by the mouse used for raising such Jackson Laboratory (Bar Harbor, Maine) or from the Core Mouse
Breeding Facility at Yale.clones. Thus, it seems likely that in this system as well,
Va is selected mainly by I-Ea chain contacts and Vb
mainly by I-Eb chain contacts (Saito and Germain, 1987).
A third reason for expecting that all TCRs will address
their MHC class II±peptide ligands in the same orienta-
tion is the recent finding that peptide plays a crucial
role in positive selection (Hogquist et al., 1994; Ashton-
Rickhardt et al., 1994; Sebzda et al., 1994). While this
is particularly clear in the case of CD8 T cells being
selected on MHC class I, some data also exists for a
role of peptide in mice bearing MHC class II. In the case
of MHC class I, it appears that peptides closely related
to the antigenic peptide but unable to stimulate a partic-
ular T cell clone are especially powerful positive selec-
Figure 8. A Schematic Representation of the Peptide Contacts of
tors for the TCR of that clone. Bevan and colleagues the D10 TCR
have made the point that peptides identical to or slightly The peptide is bound to the MHC molecule at peptide residues 1,
different from the antigenic peptide will suppress devel- 4, 6, and 9 (labeled P1, P4, P6, and P9). The D10 TCR contacts have
opment of functionally active T cells, while fully antago- been defined for peptide positions 2, 5, and 8. See Discussion for
details.nistic peptides appear to mediate the most effective
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Transgenic mice were generated by microinjection of the re- Sequencing
PCR products were purified using the Wizard DNA Clean-up Systemarranged genes encoding the D10.G4.1 a and b chain TCR into day
1 F2 C3H/B6 embryos. The b chain clone was provided by J. Kaye (Promega, Madison, Wisconsin) and directly sequenced using an
internal primer and the Taq DyeDeoxy Terminator Cycle Sequencingand vectors used in the a chain construction were provided by T.
Geiger (Geiger et al. 1993) including a Ca gene-containing cosmid Kit (Applied Biosystems, Foster City, California). Sequencing prod-
ucts were separated on Sequagel sequencing system acrylamideoriginally provided to him by D. Loh (Sha et al., 1988). D10.TCR mice
are maintained by breeding to the B10.BR strain. gels (National Diagnostics, Atlanta, Georgia) and were visualized
on an Applied Biosystems 373A DNA Sequencer. Sequence was
analyzed using MacVector software (Eastman Kodak Company,Peptides
Rochester, New York). Sequencing for I5K-specific hybridomas wasPeptides were synthesized by the W. M. Keck Biotechnology Re-
done by the W. M. Keck Biotechnology Resource Lab at the Yalesource Laboratory at Yale Medical School using tBOC chemistry.
Medical School.Peptides were characterized by RP±HPLC, amino acid analysis, and
FAB mass spectroscopy. Their sequences are as follows:
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